Recombinant Antibody Production Service - Global and China Top Players Market Share and Ranking 2023

Tables and Figures

Table 1. Recombinant Antibody Production Service Consumption Value & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Recombinant Antibody Production Service Market Restraints
Table 3. Recombinant Antibody Production Service Market Trends
Table 4. Recombinant Antibody Production Service Industry Policy
Table 5. Global Recombinant Antibody Production Service Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 6. Global Recombinant Antibody Production Service Revenue Share by Company, 2018-2023, Ranked by Data of 2022
Table 7. Global Recombinant Antibody Production Service Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 8. Global Recombinant Antibody Production Service Mergers & Acquisitions, Expansion Plans
Table 9. Global Recombinant Antibody Production Service Major Companies Product Type
Table 10. Head Office and Area Served of Key Players
Table 11. China Recombinant Antibody Production Service Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 12. China Recombinant Antibody Production Service Revenue Market Share by Company, 2018-2023
Table 13. Global Key Players of Recombinant Antibody Production Service Upstream (Raw Materials)
Table 14. Global Recombinant Antibody Production Service Typical Customers
Table 15. Recombinant Antibody Production Service Typical Distributors
Table 16. By Type, Global Recombinant Antibody Production Service Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 17. By Application, Global Recombinant Antibody Production Service Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 18. By Region, Global Recombinant Antibody Production Service Consumption Value, 2018 VS 2022 VS 2029, US$ Million
Table 19. By Region, Global Recombinant Antibody Production Service Consumption Value, 2018-2029, US$ Million
Table 20. By Country, Global Recombinant Antibody Production Service Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 21. By Country, Global Recombinant Antibody Production Service Consumption Value, 2018-2029, US$ Million
Table 22. By Country, Global Recombinant Antibody Production Service Consumption Value Market Share, 2018-2029
Table 23. evitria SA Company Information, Head Office, Market Area and Industry Position
Table 24. evitria SA Company Profile and Main Business
Table 25. evitria SA Recombinant Antibody Production Service Models, Specifications, and Application
Table 26. evitria SA Recombinant Antibody Production Service Revenue and Gross Margin, US$ Million, 2018-2023
Table 27. evitria SA Recent Developments
Table 28. Bon Opus Biosciences Company Information, Head Office, Market Area and Industry Position
Table 29. Bon Opus Biosciences Company Profile and Main Business
Table 30. Bon Opus Biosciences Recombinant Antibody Production Service Models, Specifications, and Application
Table 31. Bon Opus Biosciences Recombinant Antibody Production Service Revenue and Gross Margin, US$ Million, 2018-2023
Table 32. Bon Opus Biosciences Recent Developments
Table 33. Biomatik Company Information, Head Office, Market Area and Industry Position
Table 34. Biomatik Company Profile and Main Business
Table 35. Biomatik Recombinant Antibody Production Service Models, Specifications, and Application
Table 36. Biomatik Recombinant Antibody Production Service Revenue and Gross Margin, US$ Million, 2018-2023
Table 37. Biomatik Recent Developments
Table 38. Biointron Biological Inc. Company Information, Head Office, Market Area and Industry Position
Table 39. Biointron Biological Inc. Company Profile and Main Business
Table 40. Biointron Biological Inc. Recombinant Antibody Production Service Models, Specifications, and Application
Table 41. Biointron Biological Inc. Recombinant Antibody Production Service Revenue and Gross Margin, US$ Million, 2018-2023
Table 42. Biointron Biological Inc. Recent Developments
Table 43. Sino Biological Company Information, Head Office, Market Area and Industry Position
Table 44. Sino Biological Company Profile and Main Business
Table 45. Sino Biological Recombinant Antibody Production Service Models, Specifications, and Application
Table 46. Sino Biological Recombinant Antibody Production Service Revenue and Gross Margin, US$ Million, 2018-2023
Table 47. Sino Biological Recent Developments
Table 48. ProSci Inc Company Information, Head Office, Market Area and Industry Position
Table 49. ProSci Inc Company Profile and Main Business
Table 50. ProSci Inc Recombinant Antibody Production Service Models, Specifications, and Application
Table 51. ProSci Inc Recombinant Antibody Production Service Revenue and Gross Margin, US$ Million, 2018-2023
Table 52. ProSci Inc Recent Developments
Table 53. GenScript Company Information, Head Office, Market Area and Industry Position
Table 54. GenScript Company Profile and Main Business
Table 55. GenScript Recombinant Antibody Production Service Models, Specifications, and Application
Table 56. GenScript Recombinant Antibody Production Service Revenue and Gross Margin, US$ Million, 2018-2023
Table 57. GenScript Recent Developments
Table 58. RayBiotech Company Information, Head Office, Market Area and Industry Position
Table 59. RayBiotech Company Profile and Main Business
Table 60. RayBiotech Recombinant Antibody Production Service Models, Specifications, and Application
Table 61. RayBiotech Recombinant Antibody Production Service Revenue and Gross Margin, US$ Million, 2018-2023
Table 62. RayBiotech Recent Developments
Table 63. Cygnus Technologies Company Information, Head Office, Market Area and Industry Position
Table 64. Cygnus Technologies Company Profile and Main Business
Table 65. Cygnus Technologies Recombinant Antibody Production Service Models, Specifications, and Application
Table 66. Cygnus Technologies Recombinant Antibody Production Service Revenue and Gross Margin, US$ Million, 2018-2023
Table 67. Cygnus Technologies Recent Developments
Table 68. Cusabio Technology Company Information, Head Office, Market Area and Industry Position
Table 69. Cusabio Technology Company Profile and Main Business
Table 70. Cusabio Technology Recombinant Antibody Production Service Models, Specifications, and Application
Table 71. Cusabio Technology Recombinant Antibody Production Service Revenue and Gross Margin, US$ Million, 2018-2023
Table 72. Cusabio Technology Recent Developments
Table 73. Absolute Antibody Company Information, Head Office, Market Area and Industry Position
Table 74. Absolute Antibody Company Profile and Main Business
Table 75. Absolute Antibody Recombinant Antibody Production Service Models, Specifications, and Application
Table 76. Absolute Antibody Recombinant Antibody Production Service Revenue and Gross Margin, US$ Million, 2018-2023
Table 77. Absolute Antibody Recent Developments
Table 78. Cayman Chemical Company Information, Head Office, Market Area and Industry Position
Table 79. Cayman Chemical Company Profile and Main Business
Table 80. Cayman Chemical Recombinant Antibody Production Service Models, Specifications, and Application
Table 81. Cayman Chemical Recombinant Antibody Production Service Revenue and Gross Margin, US$ Million, 2018-2023
Table 82. Cayman Chemical Recent Developments
Table 83. Creative Biolabs Company Information, Head Office, Market Area and Industry Position
Table 84. Creative Biolabs Company Profile and Main Business
Table 85. Creative Biolabs Recombinant Antibody Production Service Models, Specifications, and Application
Table 86. Creative Biolabs Recombinant Antibody Production Service Revenue and Gross Margin, US$ Million, 2018-2023
Table 87. Creative Biolabs Recent Developments
Table 88. Promab Biotechnologies Company Information, Head Office, Market Area and Industry Position
Table 89. Promab Biotechnologies Company Profile and Main Business
Table 90. Promab Biotechnologies Recombinant Antibody Production Service Models, Specifications, and Application
Table 91. Promab Biotechnologies Recombinant Antibody Production Service Revenue and Gross Margin, US$ Million, 2018-2023
Table 92. Promab Biotechnologies Recent Developments
Table 93. Leinco Technologies Company Information, Head Office, Market Area and Industry Position
Table 94. Leinco Technologies Company Profile and Main Business
Table 95. Leinco Technologies Recombinant Antibody Production Service Models, Specifications, and Application
Table 96. Leinco Technologies Recombinant Antibody Production Service Revenue and Gross Margin, US$ Million, 2018-2023
Table 97. Leinco Technologies Recent Developments
Table 98. R&D Systems Company Information, Head Office, Market Area and Industry Position
Table 99. R&D Systems Company Profile and Main Business
Table 100. R&D Systems Recombinant Antibody Production Service Models, Specifications, and Application
Table 101. R&D Systems Recombinant Antibody Production Service Revenue and Gross Margin, US$ Million, 2018-2023
Table 102. R&D Systems Recent Developments
Table 103. Rapid Novor Company Information, Head Office, Market Area and Industry Position
Table 104. Rapid Novor Company Profile and Main Business
Table 105. Rapid Novor Recombinant Antibody Production Service Models, Specifications, and Application
Table 106. Rapid Novor Recombinant Antibody Production Service Revenue and Gross Margin, US$ Million, 2018-2023
Table 107. Rapid Novor Recent Developments
Table 108. ACROBiosystems Company Information, Head Office, Market Area and Industry Position
Table 109. ACROBiosystems Company Profile and Main Business
Table 110. ACROBiosystems Recombinant Antibody Production Service Models, Specifications, and Application
Table 111. ACROBiosystems Recombinant Antibody Production Service Revenue and Gross Margin, US$ Million, 2018-2023
Table 112. ACROBiosystems Recent Developments
List of Figures
Figure 1. Recombinant Antibody Production Service Picture
Figure 2. Global Recombinant Antibody Production Service Consumption Value, (US$ million) & (2018-2029)
Figure 3. China Recombinant Antibody Production Service Consumption Value, (US$ million) & (2018-2029)
Figure 4. By Consumption Value, China Recombinant Antibody Production Service Market Share of Global, 2018-2029
Figure 5. Global Recombinant Antibody Production Service Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022
Figure 6. China Recombinant Antibody Production Service Key Participants, Market Share, 2022
Figure 7. Recombinant Antibody Production Service Industry Chain
Figure 8. Recombinant Antibody Production Service Procurement Model
Figure 9. Recombinant Antibody Production Service Sales Model
Figure 10. Recombinant Antibody Production Service Sales Channels, Direct Sales, and Distribution
Figure 11. High-throughput Antibody Production Service
Figure 12. Small to Mid-scale Antibody Production Service
Figure 13. Large-scale Antibody Production Service
Figure 14. Chimeric Antibody Production Service
Figure 15. Antibody Fragment Production Service
Figure 16. Bispecific Antibody Production Service
Figure 17. Others
Figure 18. By Type, Global Recombinant Antibody Production Service Consumption Value, 2018-2029, US$ Million
Figure 19. By Type, Global Recombinant Antibody Production Service Consumption Value Market Share, 2018-2029
Figure 20. Pharmaceutical
Figure 21. Biotechnology Company
Figure 22. Others
Figure 23. By Application, Global Recombinant Antibody Production Service Consumption Value, 2018-2029, US$ Million
Figure 24. By Application, Global Recombinant Antibody Production Service Consumption Value Market Share, 2018-2029
Figure 25. By Region, Global Recombinant Antibody Production Service Consumption Value Market Share, 2018-2029
Figure 26. North America Recombinant Antibody Production Service Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 27. By Country, North America Recombinant Antibody Production Service Consumption Value Market Share, 2022
Figure 28. Europe Recombinant Antibody Production Service Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 29. By Country, Europe Recombinant Antibody Production Service Consumption Value Market Share, 2022
Figure 30. Asia Pacific Recombinant Antibody Production Service Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 31. By Country/Region, Asia Pacific Recombinant Antibody Production Service Consumption Value Market Share, 2022
Figure 32. South America Recombinant Antibody Production Service Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 33. By Country, South America Recombinant Antibody Production Service Consumption Value Market Share, 2022
Figure 34. Middle East & Africa Recombinant Antibody Production Service Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 35. U.S. Recombinant Antibody Production Service Consumption Value, 2018-2029, US$ Million
Figure 36. By Type, U.S. Recombinant Antibody Production Service Consumption Value Market Share, 2022 VS 2029
Figure 37. By Application, U.S. Recombinant Antibody Production Service Consumption Value Market Share, 2022 VS 2029
Figure 38. Europe Recombinant Antibody Production Service Consumption Value, 2018-2029, US$ Million
Figure 39. By Type, Europe Recombinant Antibody Production Service Consumption Value Market Share, 2022 VS 2029
Figure 40. By Application, Europe Recombinant Antibody Production Service Consumption Value Market Share, 2022 VS 2029
Figure 41. China Recombinant Antibody Production Service Consumption Value, 2018-2029, US$ Million
Figure 42. By Type, China Recombinant Antibody Production Service Consumption Value Market Share, 2022 VS 2029
Figure 43. By Application, China Recombinant Antibody Production Service Consumption Value Market Share, 2022 VS 2029
Figure 44. Japan Recombinant Antibody Production Service Consumption Value, 2018-2029, US$ Million
Figure 45. By Type, Japan Recombinant Antibody Production Service Consumption Value Market Share, 2022 VS 2029
Figure 46. By Application, Japan Recombinant Antibody Production Service Consumption Value Market Share, 2022 VS 2029
Figure 47. South Korea Recombinant Antibody Production Service Consumption Value, 2018-2029, US$ Million
Figure 48. By Type, South Korea Recombinant Antibody Production Service Consumption Value Market Share, 2022 VS 2029
Figure 49. By Application, South Korea Recombinant Antibody Production Service Consumption Value Market Share, 2022 VS 2029
Figure 50. Southeast Asia Recombinant Antibody Production Service Consumption Value, 2018-2029, US$ Million
Figure 51. By Type, Southeast Asia Recombinant Antibody Production Service Consumption Value Market Share, 2022 VS 2029
Figure 52. By Application, Southeast Asia Recombinant Antibody Production Service Consumption Value Market Share, 2022 VS 2029
Figure 53. India Recombinant Antibody Production Service Consumption Value, 2018-2029, US$ Million
Figure 54. By Type, India Recombinant Antibody Production Service Consumption Value Market Share, 2022 VS 2029
Figure 55. By Application, India Recombinant Antibody Production Service Consumption Value Market Share, 2022 VS 2029
Figure 56. Middle East & Africa Recombinant Antibody Production Service Consumption Value, 2018-2029, US$ Million
Figure 57. By Type, Middle East & Africa Recombinant Antibody Production Service Consumption Value Market Share, 2022 VS 2029
Figure 58. By Application, Middle East & Africa Recombinant Antibody Production Service Consumption Value Market Share, 2022 VS 2029
Figure 59. Research Methodology
Figure 60. Breakdown of Primary Interviews
Figure 61. Bottom-up and Top-down Approaches
Figure 62. Top-down Approaches

Reason to Buy

• Current and future of Service & Software Market outlook in the developed and emerging markets
• Highlights key business priorities in order to assist companies to realign their business strategies
• The segment that is expected to dominate the Service & Software Market
• Regions that are expected to witness the fastest growth during the forecast period
• Identify the latest developments, Service & Software Market shares, and strategies employed by the major market players
• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Service & Software Market
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets